-The Hindu   With water becoming an important cost, and with climate change and soil degradation, the System of Rice Intensification offers disadvantaged farming households better opportunities A truant monsoon is in the offing, with El Niño weather patterns expected to bring about drier conditions. India has the world's largest area devoted to rice, a very water-intensive crop. This is a good time for giving impetus to "more crop per drop" practices, now...

-The Hindu   Kannur (Kerala): The ‘kaipad' rice cultivated in the brackish water tracts of northern parts of the State has been included in the Geographical Indications (GI) registry in the country which is part of the Intellectual Property regime. The notification of inclusion of the ‘kaipad' rice varieties in the GI registry followed an application submitted by the Malabar Kaipad Farmers' Society (MKFS) of Ezhome here. The society has been formed for...

Gene Campaign turned twenty in 2013. Starting in 1993 as a leading research and advocacy organization, GC dedicated itself to the conservation of genetic resources and indigenous knowledge. The campaign has encouraged self reliance and worked towards ensuring livelihood security for rural and tribal communities. Closely involved in policymaking and legislation with respect to biological resources, GC has enabled rural and adivasi communities to participate in policies relating to these...

-The Hindu   No one can attack India's well-founded Intellectual Property regime as being weak merely because a drug that is claimed to be an invention fails the test of law India and its intellectual property (IP) laws have been the subject of sharp criticism recently. Now, there is talk of the government invoking emergency provisions with regard to Dasatinib, a cancer drug. The decibel level may go up several notches. Let us look...

-The Hindu Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India's economic relations with the U.S. The attempt by the influential pharmaceutical lobby to stymie India's efforts to ensure the supply of medicines at affordable rates without violating existing treaty commitments, requires a principled response from New Delhi. At the core of the issue is what Columbia University Professor Arvind Panagariya calls "the hijacking of...